NASDAQ:APLS - Apellis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$16.31 -0.66 (-3.89 %)
(As of 12/19/2018 04:06 AM ET)
Previous Close$16.97
Today's Range$15.74 - $18.12
52-Week Range$11.45 - $32.00
Volume375,800 shs
Average Volume281,603 shs
Market Capitalization$1.05 billion
P/E Ratio-4.44
Dividend YieldN/A

Analyst Ratings

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Apellis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $41.40, suggesting that the stock has a possible upside of 153.83%. The high price target for APLS is $53.00 and the low price target for APLS is $34.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $41.40$38.00$38.20$34.25
Price Target Upside: 153.83% upside158.50% upside103.08% upside65.38% upside

Apellis Pharmaceuticals (NASDAQ:APLS) Consensus Price Target History

Price Target History for Apellis Pharmaceuticals (NASDAQ:APLS)

Apellis Pharmaceuticals (NASDAQ:APLS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/6/2018CitigroupBoost Price TargetBuy$34.00 ➝ $40.00MediumView Rating Details
12/3/2018Cantor FitzgeraldSet Price TargetBuy$53.00HighView Rating Details
11/14/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$38.00 ➝ $34.00HighView Rating Details
9/13/2018B. RileyBoost Price TargetBuy$27.00 ➝ $40.00LowView Rating Details
8/1/2018CowenReiterated RatingBuy$40.00MediumView Rating Details
12/4/2017Evercore ISIInitiated CoverageOutperformHighView Rating Details
(Data available from 12/19/2016 forward)
This page was last updated on 12/19/2018 by Staff

Featured Article: Fiduciary

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel